US$ 21.70
glp-1 obesity drug news today october 16 2025 Market 2024 was a record year
Description
Because our carb and fat intake has increased so much relative to carbohydrates, our overall percentage of total calories from protein (i.e., protein %) has decreased

Weight loss is typically a combination of body fat loss and lean muscle mass reduction

Sources Lilly Retatrutide TRIUMPH-1 Phase 3 Topline Results FDA Concerns With Unapproved GLP-1 Drugs Used for Weight Loss FDA Wegovy Prescribing Information FDA Zepbound Prescribing Information Dr

The growing popularity of GLP-1 treatments has influenced everything from local healthcare supply chains to dining culture, with some Dubai restaurants now offering smaller portion menus to cater to those using appetite-suppressing drugs
The experiences shared in these spaces reflect the day-to-day reality of figuring out what your body will and won't tolerate